2011i-660 2011l-127 2012f-683 administration biomedicalresearch costeffectiveness drugandnarcoticcontrol drugapproval drugindustry drugs economicaspects economics ethics governmentregulation healthcarereform healthworkforce interdisciplinarycommunication jurisprudence legislation marketing methods moralandethicalaspects organization patentsastopic pharmaceutical pharmaceuticalindustry pharmaceuticalpolicy pharmaceuticalpreparations technology trends